Actively Recruiting
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-06-26
125
Participants Needed
1
Research Sites
865 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.
CONDITIONS
Official Title
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with peritoneal carcinomatosis of colorectal origin, pseudomyxoma peritonei (type DPAM or PMCA), or peritoneal mesothelioma
- Planned to undergo cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) due to a peritoneal surface malignancy
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Clinics Gasthuisberg
Leuven, Flemish Brabant, Belgium, 3000
Actively Recruiting
Research Team
I
Isabelle B Terrasson
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here